Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Elucidating the Role of Leucine-Rich Repeat Kinase 2 in Crohn’s Disease Pathogenesis
EF 2021-22
Résumé
Crohns disease (CD) is a debilitating chronic inflammatory bowel disease that is primarily characterised by lesions along the digestive tract which trigger abdominal pain, diarrhea, rectal bleeding, weight loss, and fatigue. Despite the diseases increasing prevalence, its cause is not known. Nevertheless, certain factors, including mutations of specific genes, have been associated with its development. One of these genes ; leucine-rich repeat kinase 2 (LRRK2), which is highly expressed in white blood cells ; remains understudied in the context of CD and is interestingly also associated with Parkinsons disease (PD). The LRRK2 variants linked to both diseases result in a similarly aberrant and hyperactive protein. Although CD and PD seem unrelated, the presence of this shared genetic risk factor suggests that similar processes underlie their inflammatory nature.The research that we propose seeks to shed light on the normal function of LRRK2 in white blood cells and the role of mutant hyperactive LRRK2 in mediating intestinal inflammation. Our labs preliminary findings have shown that white blood cells lacking functional LRRK2 experience a number of defects that impair their ability to migrate to sites of infection and kill invading microbes. Our proposed research will further investigate how these defects arise and will also explore the CD-associated LRRK2 variants in cells and mice in order to understand how they promote intestinal inflammation. We hypothesise that LRRK2 walks a fine line between mediating efficient pathogen clearance during an infection and eliciting harmful collateral hyperinflammation. As we uncover the role of LRRK2 in CD development, we hope to explore therapeutic strategies that specifically target aberrant LRRK2 activity.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
467083
Name
Samman Bana
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the Role of Leucine-Rich Repeat Kinase 2 in Crohn’s Disease Pathogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Crohn'S Disease; Inflammation; Lrrk2; Neutrophils
Abstract
Crohns disease (CD) is a debilitating chronic inflammatory bowel disease that is primarily characterised by lesions along the digestive tract which trigger abdominal pain, diarrhea, rectal bleeding, weight loss, and fatigue. Despite the diseases increasing prevalence, its cause is not known. Nevertheless, certain factors, including mutations of specific genes, have been associated with its development. One of these genes ; leucine-rich repeat kinase 2 (LRRK2), which is highly expressed in white blood cells ; remains understudied in the context of CD and is interestingly also associated with Parkinsons disease (PD). The LRRK2 variants linked to both diseases result in a similarly aberrant and hyperactive protein. Although CD and PD seem unrelated, the presence of this shared genetic risk factor suggests that similar processes underlie their inflammatory nature.The research that we propose seeks to shed light on the normal function of LRRK2 in white blood cells and the role of mutant hyperactive LRRK2 in mediating intestinal inflammation. Our labs preliminary findings have shown that white blood cells lacking functional LRRK2 experience a number of defects that impair their ability to migrate to sites of infection and kill invading microbes. Our proposed research will further investigate how these defects arise and will also explore the CD-associated LRRK2 variants in cells and mice in order to understand how they promote intestinal inflammation. We hypothesise that LRRK2 walks a fine line between mediating efficient pathogen clearance during an infection and eliciting harmful collateral hyperinflammation. As we uncover the role of LRRK2 in CD development, we hope to explore therapeutic strategies that specifically target aberrant LRRK2 activity.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Samman, Bana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~